DDev Plastiks Q2 FY26: Margin Pressures Weigh Despite Revenue Growth

Nov 19 2025 09:30 AM IST
share
Share Via
DDev Plastiks Industries Ltd., a leading polymer compound manufacturer with an installed capacity of 2,61,500 MTPA, reported a mixed performance in Q2 FY26, with net profit declining sequentially despite robust year-on-year revenue growth. The company posted a net profit of ₹47.11 crores for the quarter ended September 2025, representing a 9.66% decline from the preceding quarter's ₹52.15 crores, though up 5.34% compared to ₹44.72 crores in the same period last year. The stock, with a market capitalisation of ₹2,904.59 crores, has witnessed considerable volatility in recent months, currently trading at ₹280.70, down 22.03% from its 52-week high of ₹360.00.





Net Profit (Q2 FY26)

₹47.11 Cr

▼ 9.66% QoQ

▲ 5.34% YoY



Revenue (Q2 FY26)

₹680.15 Cr

▼ 11.58% QoQ

▲ 17.20% YoY



Operating Margin

9.39%

▼ 9 bps QoQ



Return on Equity

24.67%

Strong Capital Efficiency




The quarter's results reveal a company navigating through operational headwinds whilst maintaining reasonable year-on-year growth momentum. Revenue for Q2 FY26 stood at ₹680.15 crores, down 11.58% sequentially from ₹769.22 crores in Q1 FY26, but up a healthy 17.20% compared to ₹580.35 crores in Q2 FY25. The sequential revenue decline, however, raises questions about demand patterns and seasonal factors affecting the polymer compounds business.



Most concerning is the compression in operating margins, which declined to 9.39% in Q2 FY26 from 9.48% in the previous quarter and significantly below the 10.98% achieved in the same period last year. This margin erosion, despite reasonable revenue growth on a year-on-year basis, points to rising input costs or competitive pressures that the company has been unable to fully pass through to customers. The profit after tax margin similarly declined to 6.93% from 6.78% in Q1 FY26, though it remains below the 7.71% achieved in Q2 FY25.









































































Quarter Revenue (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin
Sep'25 680.15 -11.58% 47.11 -9.66% 9.39%
Jun'25 769.22 +4.40% 52.15 +0.81% 9.48%
Mar'25 736.79 +11.51% 51.73 +10.99% 10.38%
Dec'24 660.75 +13.85% 46.60 +4.20% 10.65%
Sep'24 580.35 -7.21% 44.72 +5.35% 10.98%
Jun'24 625.43 +4.72% 42.45 -31.02% 9.34%
Mar'24 597.26 61.53 14.04%



Financial Performance: Sequential Weakness Amid YoY Growth



Whilst the headline year-on-year revenue growth of 17.20% appears encouraging, the sequential decline of 11.58% from Q1 FY26 warrants closer examination. On a half-yearly basis (H1 FY26), the company reported revenue of ₹1,449.37 crores, representing a 20.20% increase compared to H1 FY25. This suggests that the company's growth trajectory remains positive on an annual comparison basis, though quarterly volatility has increased.



The operating profit (PBDIT) excluding other income stood at ₹63.87 crores in Q2 FY26, down from ₹72.91 crores in the previous quarter. The operating margin compression to 9.39% from 9.48% sequentially—and more significantly from 10.98% in Q2 FY25—indicates that the company is facing pressure on its core business profitability. This margin erosion has occurred despite relatively stable employee costs at ₹13.31 crores compared to ₹11.46 crores in Q1 FY26.



Interest costs increased to ₹6.86 crores from ₹5.52 crores in the previous quarter, reflecting higher working capital requirements or borrowing costs. Depreciation remained stable at ₹4.23 crores compared to ₹4.13 crores in Q1 FY26. The effective tax rate of 25.86% in Q2 FY26 was marginally higher than the 25.23% in the previous quarter, in line with corporate tax norms.





Net Sales (Q2 FY26)

₹680.15 Cr

▼ 11.58% QoQ

▲ 17.20% YoY



Net Profit (Q2 FY26)

₹47.11 Cr

▼ 9.66% QoQ

▲ 5.34% YoY



Operating Margin

9.39%

Declined from 10.98% YoY



PAT Margin

6.93%

Below 7.71% YoY




One positive development was the increase in other income to ₹10.76 crores in Q2 FY26 from ₹6.49 crores in Q1 FY26, though this non-operating income boost could not fully offset the weakness in core operations. The profit before tax of ₹63.54 crores represented a 8.90% decline from ₹69.75 crores in the previous quarter.



Operational Excellence: Strong ROE Amidst Margin Pressures



Despite the quarterly headwinds, DDev Plastiks continues to demonstrate strong capital efficiency with an average return on equity of 24.67% and a latest ROE of 21.57%. These figures compare favourably with many peers in the specialty chemicals sector and underscore the company's ability to generate attractive returns on shareholder capital. Higher ROE indicates better capital efficiency and profitability, representing a core strength for the company even as it navigates near-term margin pressures.



The company's return on capital employed (ROCE) remains robust at 29.69% on average and 31.54% for the latest period. This metric, which measures how efficiently a company uses its capital to generate profits, positions DDev Plastiks favourably within the specialty chemicals industry. The strong ROCE reflects the company's operational efficiency and its ability to deploy capital productively in its polymer compounds manufacturing business.



From a balance sheet perspective, DDev Plastiks maintains a virtually debt-free structure with net debt to equity at -0.08, effectively making it a net cash company. Shareholder funds stood at ₹834.71 crores as of March 2025, up from ₹659.87 crores in the previous year. The company's fixed assets increased to ₹270.66 crores from ₹230.72 crores, indicating ongoing capacity expansion efforts to support future growth.




Margin Compression: A Key Concern


The decline in operating margins from 10.98% in Q2 FY25 to 9.39% in Q2 FY26 represents a significant 159 basis points compression. This trend, if sustained, could materially impact profitability despite volume growth. The company needs to demonstrate pricing power or cost management improvements in coming quarters to restore investor confidence in margin sustainability.




Working capital management appears to have tightened, with current assets at ₹860.77 crores against current liabilities of ₹286.39 crores as of March 2025. The company's current ratio remains healthy, providing adequate liquidity to meet short-term obligations. Trade payables stood at ₹202.37 crores, up from ₹181.24 crores in the previous year, reflecting higher business activity levels.



Industry Context: Navigating Specialty Chemicals Volatility



The specialty chemicals sector in India has witnessed considerable volatility over the past year, with companies grappling with fluctuating raw material costs, changing demand patterns, and increased competition. DDev Plastiks, with its focus on polymer compounds including PE compounds, PVC compounds, filler compounds, master batches, and footwear compounds, operates in a segment that serves diverse end-user industries including automotive, construction, and consumer goods.



The company's product portfolio expansion into engineering plastic compounds for white goods, automotive applications, and electrical appliances positions it to capture growth opportunities across multiple sectors. However, this diversification also exposes the company to cyclical demand patterns in these industries, which could explain some of the quarterly revenue volatility observed in recent periods.



The polymer compounds market in India is characterised by both organised and unorganised players, with pricing power dependent on product quality, technical capabilities, and customer relationships. DDev Plastiks' installed capacity of 2,61,500 MTPA provides scale advantages, though capacity utilisation levels and the competitive intensity in specific product segments remain key variables affecting profitability.




Capacity Expansion: Positioning for Growth


The increase in fixed assets from ₹230.72 crores in March 2024 to ₹270.66 crores in March 2025 indicates ongoing capital expenditure, likely aimed at expanding production capacity or upgrading facilities. This investment, whilst pressuring near-term returns, could position the company to capitalise on demand recovery when market conditions improve.




Peer Comparison: Valuation Advantage with Quality Concerns



When compared to peers in the specialty chemicals sector, DDev Plastiks trades at a considerable valuation discount. The company's price-to-earnings ratio of 14.90x is substantially lower than peers such as Neogen Chemicals (97.23x), Foseco India (40.61x), and Rossari Biotech (25.39x). However, this valuation gap reflects both the company's smaller scale and concerns about near-term earnings trajectory.

































































Company P/E (TTM) P/BV ROE % Debt/Equity Div Yield %
DDev Plastiks 14.90 3.21 24.67 -0.08 0.62
Rossari Biotech 25.39 2.77 11.87 0.22
Neogen Chemicals 97.23 4.29 9.65 1.23 0.08
Foseco India 40.61 9.07 19.68 -0.78 0.48
Vishnu Chemicals 23.49 3.25 20.05 0.27 0.06
Camlin Fine 348.57 3.41 5.57 0.58



DDev Plastiks' superior ROE of 24.67% stands out amongst peers, significantly ahead of Vishnu Chemicals (20.05%), Foseco India (19.68%), Rossari Biotech (11.87%), and Neogen Chemicals (9.65%). This higher return on equity, combined with a debt-free balance sheet, represents a key competitive advantage. The company's price-to-book value of 3.21x appears reasonable given the strong ROE, though it trades at a premium to Rossari Biotech's 2.77x.



The dividend yield of 0.62% is modest but reflects the company's preference to retain earnings for growth investments rather than distribute cash to shareholders. With a dividend payout ratio of just 9.76%, there remains significant scope for increased distributions if the management chooses to reward shareholders more generously in future periods.



Valuation Analysis: Attractive Entry Point Despite Near-Term Concerns



At the current market price of ₹280.70, DDev Plastiks trades at a P/E ratio of 15x based on trailing twelve months earnings, representing a significant discount to the specialty chemicals industry average P/E of 42x. The stock's price-to-book value of 3.21x appears reasonable given the company's ROE of 24.67%, though the PEG ratio of 3.19 suggests the valuation may be somewhat stretched relative to near-term growth expectations.



The stock has corrected 22.03% from its 52-week high of ₹360.00, currently trading closer to the lower end of its annual range. The 52-week low stands at ₹212.75, providing a downside cushion of 31.94% from current levels. This correction has brought valuations to more attractive levels, with the proprietary valuation grade recently upgraded to "Very Attractive" from "Attractive" in October 2025.





P/E Ratio (TTM)

15.0x

vs Industry 42x



Price to Book

3.21x

ROE: 24.67%



EV/EBITDA

10.14x

Reasonable Multiple



Dividend Yield

0.62%

₹1.75 per share




The enterprise value to EBITDA multiple of 10.14x and EV to sales of 1.01x suggest reasonable valuations, particularly for a company with strong return ratios and minimal debt. However, the PEG ratio of 3.19 indicates that the market is pricing in slower growth expectations, likely reflecting concerns about margin pressures and quarterly earnings volatility.



From a technical perspective, the stock has been trading in a sideways pattern since mid-November 2025, following a period of mildly bearish momentum. The stock currently trades below all key moving averages—5-day (₹285.66), 20-day (₹296.34), 50-day (₹319.13), 100-day (₹309.14), and 200-day (₹286.28)—indicating weak near-term momentum and lack of buying interest.



Shareholding Pattern: Stable Promoter Base with Minimal Institutional Interest



The shareholding structure of DDev Plastiks has remained remarkably stable over recent quarters, with promoter holding steady at 75.00% across the past five quarters. The promoter group, led by Bbigplas Poly Private Limited (74.17%), Ddev Surana (0.73%), and family members, demonstrates strong commitment to the business with zero pledging of shares—a positive indicator of management confidence.



















































Shareholder Category Sep'25 Jun'25 Mar'25 QoQ Change
Promoter Holding 75.00% 75.00% 75.00% 0.00%
FII Holding 1.13% 0.36% 0.36% +0.77%
Mutual Fund 0.00% 0.00% 0.00% 0.00%
Other DII 0.80% 1.15% 0.52% -0.35%
Non-Institutional 23.07% 23.50% 24.12% -0.43%



Foreign institutional investor (FII) holding increased notably to 1.13% in September 2025 from 0.36% in June 2025, representing a 0.77 percentage point sequential increase. This uptick suggests growing interest from foreign investors, though the absolute level remains modest with just 15 FII holders. Mutual fund participation remains conspicuously absent at 0.00%, indicating limited interest from domestic institutional investors.



Other domestic institutional investor (DII) holdings declined to 0.80% from 1.15% in the previous quarter, a reduction of 0.35 percentage points. Non-institutional shareholding, which includes retail and high-net-worth individuals, decreased marginally to 23.07% from 23.50%. The total institutional holding of just 1.93% highlights the stock's limited visibility amongst institutional investors, which could constrain liquidity and price discovery.



Stock Performance: Underperformance Across Timeframes



DDev Plastiks' stock performance has been lacklustre across most timeframes, with the shares underperforming both the broader market and the specialty chemicals sector. Over the past year, the stock has delivered returns of just 4.74% compared to the Sensex's 9.46% gain, resulting in negative alpha of 4.72 percentage points. The underperformance versus the specialty chemicals sector return of 5.95% further underscores relative weakness.































































Period Stock Return Sensex Return Alpha
1 Week -3.34% +0.53% -3.87%
1 Month -7.31% +1.15% -8.46%
3 Months -13.18% +4.01% -17.19%
6 Months +4.35% +3.48% +0.87%
YTD +1.94% +8.68% -6.74%
1 Year +4.74% +9.46% -4.72%
2 Years +36.86% +29.07% +7.79%
3 Years +227.44% +37.71% +189.73%



The near-term performance has been particularly weak, with the stock declining 3.34% over the past week, 7.31% over one month, and 13.18% over three months. This consistent underperformance has resulted in significant negative alpha of 3.87%, 8.46%, and 17.19% respectively over these periods. The year-to-date return of 1.94% trails the Sensex's 8.68% gain by a considerable margin.



On a positive note, the longer-term picture appears more favourable. Over two years, the stock has delivered returns of 36.86% compared to the Sensex's 29.07%, generating positive alpha of 7.79%. The three-year performance is particularly impressive, with the stock surging 227.44% compared to the Sensex's 37.71% gain, resulting in exceptional alpha of 189.73%. This historical outperformance reflects the company's strong growth trajectory since its incorporation in December 2020.



From a risk perspective, the stock exhibits high volatility with a standard deviation of 51.28% over the past year, significantly higher than the Sensex's 12.25%. The beta of 1.35 indicates that the stock is more volatile than the broader market, amplifying both gains and losses. The risk-adjusted return of 0.09 compares unfavourably with the Sensex's 0.77, placing DDev Plastiks in the "high risk medium return" category.




"The divergence between strong three-year returns and weak recent performance encapsulates the investment dilemma: a high-growth story facing near-term execution challenges and margin pressures."


Investment Thesis: Quality Business Facing Cyclical Headwinds



DDev Plastiks presents a complex investment case characterised by strong fundamental quality metrics offset by concerning near-term operational trends. The company's average ROE of 24.67% and ROCE of 29.69% demonstrate superior capital efficiency compared to many specialty chemicals peers. The debt-free balance sheet with net cash position provides financial flexibility and reduces business risk.



However, the sequential decline in revenue and persistent margin compression raise questions about demand sustainability and pricing power. The flat financial trend designation for Q2 FY26, following a positive trend in Q1 FY26, suggests that the company's growth momentum has stalled. The proprietary advisory score of 48 out of 100, resulting in a "SELL" rating, reflects these mixed signals and the downgrade from "BUY" status in October 2025.





Valuation Grade

Very Attractive

Upgraded Oct'25



Quality Grade

Average

Long-term Performance



Financial Trend

Flat

Downgraded from Positive



Technical Trend

Sideways

Below All MAs




The technical picture reinforces the cautious stance, with the stock trading in a sideways pattern and positioned below all major moving averages. The MACD indicator shows mildly bearish signals on both weekly and monthly timeframes, whilst the Bollinger Bands suggest bearish momentum. The absence of institutional interest, with just 1.93% institutional holdings and zero mutual fund participation, limits potential catalysts for re-rating.



Key Strengths & Risk Factors





KEY STRENGTHS



  • Superior Return Ratios: ROE of 24.67% and ROCE of 29.69% demonstrate excellent capital efficiency, significantly ahead of most specialty chemicals peers

  • Debt-Free Balance Sheet: Net cash position with debt-to-equity of -0.08 provides financial flexibility and eliminates refinancing risk

  • Strong YoY Growth: Revenue growth of 17.20% YoY and 20.20% for H1 FY26 indicates robust demand on annual basis

  • Zero Promoter Pledging: Stable 75% promoter holding with no pledging demonstrates management confidence and alignment

  • Attractive Valuation: P/E of 15x versus industry average of 42x offers significant valuation discount

  • Diversified Product Portfolio: Presence across PE compounds, PVC compounds, master batches, and footwear compounds reduces concentration risk

  • Capacity Expansion: Ongoing capex with fixed assets rising to ₹270.66 crores positions company for future growth




KEY CONCERNS



  • Margin Compression: Operating margin declined to 9.39% from 10.98% YoY, representing 159 bps erosion indicating pricing pressure or cost inflation

  • Sequential Revenue Decline: Q2 FY26 revenue fell 11.58% QoQ from ₹769.22 crores to ₹680.15 crores, raising demand sustainability questions

  • Flat Financial Trend: Downgrade from "Positive" to "Flat" trend suggests momentum loss and operational challenges

  • Limited Institutional Interest: Just 1.93% institutional holdings and zero mutual fund participation constrains liquidity and limits re-rating potential

  • High Volatility: Beta of 1.35 and volatility of 51.28% indicate significant price risk compared to broader market

  • Technical Weakness: Stock trading below all moving averages with sideways trend and mildly bearish indicators

  • Small Scale: Market cap of ₹2,905 crores limits institutional participation and increases vulnerability to market downturns





Outlook: What to Watch





POSITIVE CATALYSTS



  • Margin Recovery: Stabilisation or improvement in operating margins back towards 10%+ levels would restore confidence

  • Revenue Growth Resumption: Sequential revenue growth in Q3 FY26 would indicate demand recovery and business momentum

  • Institutional Buying: Mutual fund or increased FII participation could provide liquidity and valuation support

  • Capacity Utilisation: Higher utilisation of expanded capacity could drive operating leverage and margin improvement

  • Product Mix Enhancement: Shift towards higher-margin engineering plastics and automotive compounds could boost profitability




RED FLAGS



  • Sustained Margin Pressure: Further compression below 9% would indicate structural profitability challenges

  • Continued Sequential Decline: Another quarter of QoQ revenue decline would signal deeper demand issues

  • Working Capital Deterioration: Rising inventory or receivables days indicating collection or demand challenges

  • Debt Addition: Any move away from debt-free status to fund operations would indicate cash flow stress

  • Technical Breakdown: Break below ₹270 or 200-day MA could trigger further selling pressure





The coming quarters will be critical in determining whether DDev Plastiks can arrest the margin decline and resume sequential revenue growth. Management commentary on demand trends, raw material cost movements, and capacity utilisation will provide important insights into the near-term trajectory. The company's ability to leverage its debt-free balance sheet and strong return ratios will be tested as it navigates this challenging operating environment.




The Verdict: Quality Business at Crossroads


SELL

Score: 48/100


For Fresh Investors: Avoid initiating positions at current levels. Whilst the valuation appears attractive and the company demonstrates strong capital efficiency, the deteriorating financial trend, margin compression, and weak technical setup present significant near-term risks. Wait for evidence of margin stabilisation and sequential revenue growth resumption before considering entry. A more attractive entry point would emerge if the stock corrects towards ₹250-260 levels with concurrent improvement in operational metrics.


For Existing Holders: Consider reducing positions or exiting entirely, particularly if holding at cost prices above ₹300. The downgrade in financial trend from "Positive" to "Flat", combined with persistent margin pressures and technical weakness, suggests limited upside in the near term. The 22% correction from highs may not be sufficient given the operational challenges. Reassess the investment case if quarterly results show improvement in margins and sequential growth, or if the stock establishes technical support with positive divergence.


Fair Value Estimate: ₹245-265 (12-15% downside from current levels), based on 13-14x P/E on normalised FY26 earnings of ₹19-20 per share, assuming margin stabilisation at 9-9.5% levels. A re-rating towards ₹320-340 would require sustained margin improvement back to 10%+ and sequential revenue growth over multiple quarters.





Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial adviser before making any investment decisions. Past performance is not indicative of future results. The views expressed are based on publicly available information and analysis as of November 21, 2025.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News